Glide sheath
Product overview
Expanding trans-radial access to include more patients
- Glide sheath Slender is designed with a proprietary thin-wall technology where the outside diameter is reduced by one French size while the inner-diameter equivalent is maintained.
- Glide sheath Slender is coated with Terumo’s proprietary hydrophilic coating, allowing for smooth insertion and removal.
Features and Benefits
The proprietary thin-wall technology and Terumo M Coat hydrophilic coating
- Per the American Heart Association, dedicated radial sheaths with hydrophilic coating combined with smaller diameter sheaths and a tapered tip design may reduce risk of arterial spasm and radial occlusion1
- Featuring Terumo’s proprietary hydrophilic coating, the Glide sheath Slender Sheath is the only thin-wall radial sheath on the market to demonstrate superior and consistent performance in lubricity and durability over time
The Glide sheath Slender Sheath is the only thin-wall sheath that demonstrated best in class performance in all of the American Heart Association’s identified critical features that lead to reduced spasm.
THE POWER OF TERUMO GLIDE TECHNOLOGY™: LUBRICITY OVER TIMES
Hydrophilic coating is critical to procedural success, Physicians need to trust that their sheath will be just as lubricous at the end of case as it is at the beginning.
The graph below demonstrates the results of recent benchtop testing. The lower the value, the more lubricious the coating. The straighter the line, the more consistent, and reliable, the performance.
Glide sheath Slender Sheath outperformed the other competitive sheaths in both key features: lubricity and lubricity over time.
Unmatched Clinical Evidence
- A meta-analysis of 10 clinical papers, involving 3,821 patients, demonstrated that use of Glide sheath Slender Sheath is associated with high rates of procedural success and low rates in performance related issues.
- In studies measuring patient comfort, patients who underwent percutaneous trans-radial procedures with the Glide sheath Slender Sheath reported none to low amounts of pain.
Related products
-
PROGREAT® MICROCATHETHER
PRODUCT OVERVIEW
PROGREAT® Microcatheters are designed to allow navigation through tortuous peripheral vessels for optimal access and delivery of therapeutic embolization.
Terumo Progreat 2.7Fr. Microcatheter is Designed to provide optimal trackability and support even in the most tortuous anatomy.
DESIGNED TO CONFIDENTLY DELIVER EMBOLOTHERAPY
- Tungsten coil reinforcement for kink resistance2
- PTFE inner layer is designed for exceptional guidewire tracking, with virtually frictionless delivery of coils and other embolics2
- DMSO Compatible3
- Radiopaque 0.7 mm platinum/iridium markers allow for rapid and precise positioning4
DESIGNED TO ENHANCE ACCESS TO SMALL PERIPHERAL VESSELS
- TERUMO Glide TechnologyTM hydrophilic coating enhances navigation through tortuous anatomy1,2
- Unique varied tungsten coil pitch construction provides distal flexibility and proximal pushability, enhancing vessel selectivity and catheter placement.
PROGREAT® COAXIAL MICROCATHETER SYSTEM
- Preloaded with uniquely designed 0.021” GLIDEWIRE® GT for the 2.8Fr system and 0.018″ GLIDEWIRE® GT for the 2.4Fr system1
- Available in 2.8Fr and 2.4Fr
- Enables simultaneous preparation of microcatheter and guidewire, which may save time and increase procedural efficiency1
PROGREAT 2.4 COAXIAL PROVEN TO REACH DISTAL VESSELS WITH EASE⁴
- Provides greater vessel selectivity and demonstrated superiority in traversing tortuous anatomy
- Provides best-in-class kink resistance, demonstrated in both the distal and proximal shaft.
PROGREAT® Microcatheter Product Codes
Includes hemostatic valve and shaping mandrel
Fr Size Product Code Length (cm) Tip Shape Max Pressure (psi) RO Markers Hydrophilic Coating Length (cm) 2.4 MC*PB2411Y 110 Straight 750 1 50 MC*PB2413Y 130 Straight 1 70 MC*PB2413ZRA 130 70 Deg. Angle 1 70 MC*PB2413ZRC 130 J Curve 1 70 MC*PV2415Y 150 Straight 2 90 MC*PV2415ZRA 150 70 Deg. Angle 2 90 MC*PV2415ZRC 150 J Curve 2 90 2.7 MC*PC2711Y 110 Straight 750 – 50 MC*PC27137 130 Straight – 70 2.8 MC*PB2811Y 110 Straight 900 1 50 MC*PB2813Y 130 Straight 1 70 MC*PV2815Y 150 Straight 2 90 PROGREAT® Coaxial Microcatheter System Codes
Includes unique GLIDEWIRE® GT Guidewire, wire stopper, guidewire introducer, hemostatic valve, 2.5 mL syringe, and shaping mandrel
Fr Size Product
CodeLength
(cm)Max Pressure
(PSI)RO Markers Hydrophilic
Coating Length
(cm)Glidewire® GT
Length
(cm)Glidewire® GT Size
(in)2.4 Fr MC*PE24111YB 110 750 1 50 120 0.018 2.4 Fr MC*PE24131YB 130 750 1 70 140 0.018 2.4 Fr MC*PE24151YV 150 750 2 90 160 0.018 2.7 Fr MC*PE27111Y 110 750 – 50 120 0.021 2.7 Fr MC*PE27131Y 130 750 – 70 140 0.021 2.8 Fr MC*PE28111YB 110 900 1 50 120 0.021 2.8 Fr MC*PE28131YB 130 900 1 70 140 0.021 2.8 Fr MC*PE28151YV 150 900 2 90 160 0.021 PRODUCT SPECIFICATIONS
Catheter OD Length
(cm)Inner Diameter
(in/mm)Max GW
(in)Embolic
CompatibilityDead Space Volume
(mL)Actual Flow Rate* (mL/sec) @ 750 psi Actual Flow Rate* (mL/sec) @ 900 psi 2.4/2.9Fr
(0.80/0.97mm)110 0.022″/0.57 0.018″ 0.018″ Coils/HydroPearl®
600 ± 75 μm0.48 2.3 – 2.4/2.9Fr
(0.80/0.97mm)130 0.022″/0.57 0.018″ 0.018″ Coils/HydroPearl®
600 ± 75 μm0.53 2 – 2.4/2.9Fr
(0.80/0.97mm)150 0.022″/0.57 0.018″ 0.018″ Coils/HydroPearl®
600 ± 75 μm0.58 1.8 – 2.7/2.9Fr
(0.90/0.97mm)110 0.025″/0.065 0.021″ 0.018″ Coils/HydroPearl®
800 ± 75 μm0.57 3.5 – 2.7/2.9Fr
(0.90/0.97mm)130 0.025″/0.065 0.021″ 0.018″ Coils/HydroPearl®
800 ± 75 μm0.64 3.2 – 2.8/3.0Fr
(0.93/1.00mm)110 0.027″/0.70 0.021″ 0.018″ Coils/HydroPearl®
800 ± 75 μm0.61 4.1 4.7 2.8/3.0Fr
(0.93/1.00mm)130 0.027″/0.70 0.021″ 0.018″ Coils/HydroPearl®
800 ± 75 μm0.68 3.7 4.3 2.8/3.0Fr
(0.93/1.00mm)150 0.027″/0.70 0.021″ 0.018″ Coils/HydroPearl®
800 ± 75 μm0.75 3.1 3.9 REFERENCES
RX ONLY. Refer to the product labels and package insert for complete warnings, precautions, potential complications, and instructions for use.
- Catheter [Instructions for Use]. Somerset, NJ: Terumo Medical Corporation; 2016
- PROGREAT Catheter 510(k); 2003
- PROGREAT DMSO Compatibility Statement Letter
- Data on file.
-
EUPHORA SEMICOMPLIANT BALLOON CATHETER
Euphora™ semicompliant balloon
Balloon Dilatation Catheter
Euphora™ semicompliant balloon dilatation catheter complements your expertise and provides uncompromising performance in the moment you need it most.
OVERVIEW
Advancing Innovation through Partnership
To develop the Euphora™ low-profile semicompliant balloon dilatation catheter, we partnered with nearly 2,000 interventional cardiologists and cath lab professionals. The result is:
- Superior deliverability1
- Superb Kissing Balloons Technique (KBT) performance2
- The lowest crossing profile compared to leading competitors3
PRODUCT DETAILS
What Makes the Euphora Balloon an Excellent Choice?
ORDERING INFORMATION
BALLOON LENGTHS 6, 10, 12, AND 15 MM
1.50 EUP1506X EUP1510X EUP1512X EUP1515X 2.00 EUP2006X EUP2010X EUP2012X EUP2015X 2.25 EUP22506X EUP22510X EUP22512X EUP22515X 2.50 EUP2506X EUP2510X EUP2512X EUP2515X 2.75 EUP27506X EUP27510X EUP27512X EUP27515X 3.00 EUP3006X EUP3010X EUP3012X EUP3015X 3.25 EUP32506X EUP32510X EUP32512X EUP32515X 3.50 EUP3506X EUP3510X EUP3512X EUP3515X 3.75 EUP37506X EUP37510X EUP37512X EUP37515X 4.00 EUP4006X EUP4010X EUP4012X EUP4015X BALLOON LENGTHS 20, 25, AND 30 MM
1.50 EUP1520X — — 2.00 EUP2020X EUP2025X EUP2030X 2.25 EUP22520X EUP22525X — 2.50 EUP2520X EUP2525X EUP2530X 2.75 EUP27520X EUP27525X — 3.00 EUP3020X EUP3025X EUP3030X 3.25 EUP32520X EUP32525X — 3.50 EUP3520X EUP3525X EUP3530X 3.75 EUP37520X EUP37525X — 4.00 EUP4020X EUP4025X EUP4030X -
NC EUPHORA NONCOMPLIANT BALLOON CATHETER
NC Euphora™ noncompliant balloon
NC Euphora™ noncompliant balloon dilatation catheter combines Euphora technology with controlled, high-pressure performance.
Balloon Dilatation Catheter
OVERVIEW
From Collaboration to Innovation
When it comes to controlled, high-pressure performance, the NC Euphora™ noncompliant balloon dilatation catheter has what you’re looking for:
- High RBP up to 20 atm
- Low-growth profile1
- Superior deliverability1
In fact, we worked with nearly 2,000 interventional cardiologists and cath lab professionals to develop it — so you can choose it with confidence for your patients.
PRODUCT DETAILS
Looking for NC Euphora Noncompliant Performance?
-
CLOSUREFAST
ClosureFast™
procedureMinimally invasive thermal
treatment for vein disease
and varicose veins.
The ClosureFast procedure uses radiofrequency energy or heat to close the diseased vein, which redirects blood flow to healthy veins, relieving symptoms.Before the procedure
You will have an ultrasound imaging exam of the leg being treated. This exam is important for assessing the diseased superficial vein and planning the procedure.
During the procedure
Your doctor will discuss the procedure with you. Here is a brief summary of what to expect:
- The ClosureFast procedure is performed on an outpatient basis. Your doctor will perform the ClosureFast procedure. Using an ultrasound, your doctor will position a catheter in the diseased vein through a small opening in the skin.
- The small catheter delivers heat to the vein wall, causing it to shrink and seal the vein. Once the diseased vein is closed, blood will reroute itself to other healthy veins.
After the procedure
- You will be taken to the recovery area to rest.
- Following the procedure, your doctor will apply a simple bandage over the insertion site and will give you compression stockings to aid in the healing process. Your doctor may encourage you to walk and to refrain from extended standing and strenuous activities for a period of time. The average patient typically resumes normal activities within a few days.1,2
- Your doctor will recommend follow-up care as needed.
-
Benefits of the ClosureFast procedure
- Relief of symptoms after two days, with a noticeable improvement in one to two week
- Minimally invasive outpatient procedure
- Less pain and bruising than laser treatment
- Faster recovery than laser treatment
- Proven results with positive patient experience
- Rapid recovery — on average, patients resume normal activities within a few days
- Lasting results — the only radiofrequency energy procedure with published long-term clinical data demonstrating safety and efficacy, with a 91.9% closure rate at five years.4
Adverse events can include nerve injury, hematoma, phlebitis, thrombosis, and/or pulmonary embolism.
Type of therapy
Thermal shrinkage of the vein wall with radiofrequency energy or heatInpatient or outpatient procedure
Outpatient procedureOne- versus two-leg treatment
Typically, each leg will be treated in separate appointmentsNeedle sticks required
One needle stick for vein access. Typically, 5 to 10 needle sticks for anesthesia.Typical post-treatment recovery
Healing of vein access site, anesthetic needle stick sites, and also healing of ablated vein sectionCompression hose
Required for approximately one weekProcedure success rate
91.9% after five years4ClosureFast procedure FAQ
Is the ClosureFast procedure painful?
Most patients report feeling little, if any, pain during the ClosureFast procedure.3 Your doctor will give you a local or regional anesthetic to numb the treatment area.
When can I return to normal activity?
Patients treated with the ClosureFast procedure may resume normal activity more quickly than patients who undergo surgical vein stripping or laser ablation. With the ClosureFast procedure, the average patient typically resumes normal activity within a few days.2 For a few weeks following the treatment, your vein specialist may recommend a regular walking regimen and suggest you refrain from strenuous activities (heavy lifting, for example) or prolonged periods of standing.
When will my symptoms improve?
Most patients report relief of symptoms after two days, with a noticeable improvement in one to two weeks.
Is there any scarring, bruising, or swelling after the procedure?
Most patients report limited to no scarring, bruising, or swelling following the ClosureFast procedure.3
How is the ClosureFast procedure different from endovenous lasers?
Both Closure Fast and lasers use thermal technology to deliver heat into the diseased vein, but they each use a different method of delivery. Despite their similarity in using heat, a 2009 study showed that the ClosureFast procedure is associated with lower rates of pain, bruising, and complications and a faster improvement in patients’ quality of life when compared to 980 nm laser ablation.4
How is the Closure Fast procedure different from vein stripping?
During vein stripping, incisions are made in the groin and calf, and a tool is threaded through the diseased vein to pull the vein out of the leg. With the ClosureFast procedure, only one small incision is made at the insertion site and the vein is then treated and left in place. ClosureFast is a minimally invasive approach that reduces the likelihood of pain and bruising, associated with vein stripping surgery.1
Is the ClosureFast procedure covered by insurance?
Many patients have access to the ClosureFast procedure through their insurance coverage plan. Insurance companies detail access to the ClosureFast procedure and other radiofrequency ablation procedures in coverage policies for varicose veins or chronic venous insufficiency. As with all healthcare procedures, you may also have some cost associated with receiving treatment, such as a copay or coinsurance. Please reach out to your insurance company to discuss your specific plan coverage and potential costs prior to seeking treatment
Quiernera –
Relative mCherry was calculated by normalizing to the WT untreated average cell value generic priligy online
Quiernera –
[url=https://fastpriligy.top/]priligy review youtube[/url] Given these data, women diagnosed with breast cancer should use hormones sparingly